VOR
Vor Biopharma Inc.Company with tickers: VOR
CIK
1817229
CUSIP
929033207
Shares Outstanding
54,185,877
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $33,291,000 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $26,701,000 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-33,291,000 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-32,486,000 | USD | 2025-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-5.21 | USD/shares | 2025-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-5.21 | USD/shares | 2025-03-31 | 10-Q | 2026-05-13 |